secwatch.observer — SEC 8-K summary
======================================

Issuer:     KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU)
CIK:        0000055529
Form:       8-K
Filed at:   2026-03-11T23:59:59+00:00
Accession:  0000055529-26-000006
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kewaunee Scientific Q3 sales +3.3% to $69.4M; diluted EPS $0.23 vs $0.45; backlog down 17% YoY
--------------------------------------------------------------------------------

- Sales $69.4M (+3.3% YoY); pre-tax earnings $1.6M (+25.8%).
- Net earnings attributable to Kewaunee $692K (diluted EPS $0.23) vs $1.35M ($0.45) prior year.
- Domestic segment sales -2.0% to $50.95M; International segment sales +21.4% to $18.45M.
- Order backlog $183.2M on Jan 31, 2026, down from $221.6M a year ago.
- Long-term debt net of sale-leaseback reduced to $16.3M from $34.1M at fiscal year end.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/55529/000005552926000006/0000055529-26-000006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/55529/000005552926000006/kequ-20260311.htm
  HTML page:      https://secwatch.observer/filing/0000055529-26-000006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer